230
Views
8
CrossRef citations to date
0
Altmetric
HEALTH ECONOMICS

Investigating the economic burden of ALS in Greece: A cost-of-illness approach

, , , , &
Pages 63-64 | Received 13 Jan 2014, Accepted 03 Jun 2014, Published online: 14 Jul 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mustafa Çoban, Uğur Bilge, Hale Balseven, Hilmi Uysal & Betül Artut. (2023) The economic evaluation of ALS care: quality and cost. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 502-513.
Read now
Lisa Meng, Amy Bian, Scott Jordan, Andrew Wolff, Jeremy M. Shefner & Jinsy Andrews. (2018) Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insurance. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 134-142.
Read now

Articles from other publishers (6)

Lidia García-Pérez, Renata Linertová, Cristina Valcárcel-Nazco, Manuel Posada, Inigo Gorostiza & Pedro Serrano-Aguilar. (2021) Cost-of-illness studies in rare diseases: a scoping review. Orphanet Journal of Rare Diseases 16:1.
Crossref
K. Achtert & L. Kerkemeyer. (2021) The economic burden of amyotrophic lateral sclerosis: a systematic review. The European Journal of Health Economics 22:8, pages 1151-1166.
Crossref
H.C. Maltezou, X. Dedoukou, E. Pavi, M. Theodoridou & K. Athanasakis. (2020) Costs associated with measles in healthcare personnel during the 2017–2018 epidemic in Greece: a real-world data cost-of-illness analysis. Journal of Hospital Infection 105:1, pages 91-94.
Crossref
Esther V Hobson, Wendy O Baird, Mike Bradburn, Cindy Cooper, Susan Mawson, Ann Quinn, Pamela J Shaw, Theresa Walsh & Christopher J McDermott. (2019) Using telehealth in motor neuron disease to increase access to specialist multidisciplinary care: a UK-based pilot and feasibility study. BMJ Open 9:10, pages e028525.
Crossref
Alan Moore, Carolyn A. Young & Dyfrig A. Hughes. (2016) Economic Studies in Motor Neurone Disease: A Systematic Methodological Review. PharmacoEconomics 35:4, pages 397-413.
Crossref
G Bertsias, E Karampli, P Sidiropoulos, I Gergianaki, A Drosos, L Sakkas, A Garyfallos, A Tzioufas, D Vassilopoulos, C Tsalapaki, P Sfikakis, S Panopoulos, K Athanasakis, A Perna, D Psomali, J Kyriopoulos & D Boumpas. (2016) Clinical and financial burden of active lupus in Greece: a nationwide study. Lupus 25:12, pages 1385-1394.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.